Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Scientists Marched To Protect NIH Grants, But Where Was Pharma?

Executive Summary

Funding from the US National Institutes of Health is a vital source for biomedical research and pharmaceutical pipelines in turn – but biopharma companies have been largely silent on the matter.

You may also be interested in...



Biotech Execs Promote Biomedical R&D At White House Meeting

At meeting led by NIH Director Collins, participants talked about importance of biomedical research and need for partnerships between industry, government and academia.

Promise Of US Tax Reform Simmers, But On The Backburner

The pharmaceutical industry will have to keep waiting for US tax reform, most likely until at least the end of 2017. President Trump plans to revisit health care reform first to generate the savings needed for "phenomenal" tax reform.

20 Drugs That Got Their Start, In Part, With US Public Funding

The Trump Administration’s budget proposal aims to slash NIH funding that's critical to drug discovery and early research. Here’s a look at 20 of the 213 FDA-approved drugs that benefited from public grants, including IO pioneer Yervoy.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

SC098673

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel